Back to results
TerminatedPhase 1

Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 Diabetes

NCT01238224

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

The Wallenberg Laboratory, Dept of Molecular and Clinical Medicine, Sahlgrenska University Hospital, Bruna stråket 16,

Gothenburg, Sweden

View on ClinicalTrials.gov
Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 Diabetes — TrialFind